CRISPR CEO pay, AstraZeneca, Bristol, Lilly
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the ...
Highly anticipated Phase 2 data for Amgen’s obesity drug show that on average, participants lost about 20% of their weight ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
AI and RNA genetic-medicine company Genetic Leap is teaming up with pharma giant Eli Lilly to develop genetic medicine therapeutics. ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Good morning. As a treat for Labor Day weekend, we’re running a deal for STAT+ subscriptions. If you use the ...
Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug Zepbound through its direct-to-consumer platform, ...
The longest clinical trial to date for a blockbuster Eli Lilly metabolic disorder drug now has data showing the treatment ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.